2021 Form 10-K Financial Statement

#000110465922041015 Filed on March 31, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $1.770M
YoY Change -36.1%
Gross Profit -$1.390M
YoY Change -33.17%
Gross Profit Margin
Selling, General & Admin $5.530M $390.0K
YoY Change 1317.95%
% of Gross Profit
Research & Development $2.460M
YoY Change -20.65%
% of Gross Profit
Depreciation & Amortization $550.0K
YoY Change 14.58%
% of Gross Profit
Operating Expenses $5.572M $260.0K $1.000K
YoY Change 1328.74%
Operating Profit -$5.572M -$1.000K
YoY Change 125.59%
Interest Expense $120.1K $90.00K
YoY Change 9.15%
% of Operating Profit
Other Income/Expense, Net $23.36M -$16.90M
YoY Change 3439.63%
Pretax Income $17.79M -$17.80M -$1.000K
YoY Change -6453.39%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $17.79M -$17.80M -$1.000K
YoY Change -6453.39%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $425.8K -$426.0K -$23.78
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 2020 Q4 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $479.7K $2.200M $0.00
YoY Change -78.2%
Cash & Equivalents $6.010M $2.246M $0.00
Short-Term Investments
Other Short-Term Assets $111.7K $300.0K $100.0K
YoY Change -62.78%
Inventory $410.0K
Prepaid Expenses $275.7K
Receivables $220.0K
Other Receivables $0.00
Total Short-Term Assets $591.4K $2.521M $100.0K
YoY Change -76.35%
LONG-TERM ASSETS
Property, Plant & Equipment $3.980M
YoY Change -10.36%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $334.4M $334.3M
YoY Change 0.04%
Other Assets $30.00K
YoY Change 0.0%
Total Long-Term Assets $334.4M $334.3M $0.00
YoY Change 0.04%
TOTAL ASSETS
Total Short-Term Assets $591.4K $2.521M $100.0K
Total Long-Term Assets $334.4M $334.3M $0.00
Total Assets $335.0M $336.8M $100.0K
YoY Change -0.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $220.0K
YoY Change -12.0%
Accrued Expenses $3.976M $208.1K $100.0K
YoY Change 1225.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.976M $334.1K $100.0K
YoY Change 1225.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $25.43M $48.70M
YoY Change 117.36%
Total Long-Term Liabilities $25.43M $48.70M $0.00
YoY Change 117.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.976M $334.1K $100.0K
Total Long-Term Liabilities $25.43M $48.70M $0.00
Total Liabilities $29.41M $49.01M $100.0K
YoY Change 145.06%
SHAREHOLDERS EQUITY
Retained Earnings -$46.38M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $305.6M -$46.38M $0.00
YoY Change
Total Liabilities & Shareholders Equity $335.0M $336.8M $100.0K
YoY Change -0.52%

Cashflow Statement

Concept 2021 2020 Q4 2020 Q2
OPERATING ACTIVITIES
Net Income $17.79M -$17.80M -$1.000K
YoY Change -6453.39%
Depreciation, Depletion And Amortization $550.0K
YoY Change 14.58%
Cash From Operating Activities -$1.749M -$60.00K -$1.000K
YoY Change 288.69%
INVESTING ACTIVITIES
Capital Expenditures $430.0K
YoY Change -50.57%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $25.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -17.00K -270.0K 25.00K
YoY Change -100.01%
NET CHANGE
Cash From Operating Activities -1.749M -60.00K -1.000K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities -17.00K -270.0K 25.00K
Net Change In Cash -1.766M -330.0K 24.00K
YoY Change -178.49%
FREE CASH FLOW
Cash From Operating Activities -$1.749M -$60.00K -$1.000K
Capital Expenditures $430.0K
Free Cash Flow -$2.179M
YoY Change 65.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1766104
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001814215
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021 twnd Threshold Trading Days For Redeem Public Shares After Completion Of Initial Business Combination
ThresholdTradingDaysForRedeemPublicSharesAfterCompletionOfInitialBusinessCombination
P10Y
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1204121
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
59200
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity Registrant Name
EntityRegistrantName
Tailwind Acquisition Corp.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity File Number
EntityFileNumber
001-39489
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1288435
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
1545 Courtney Ave
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90046
CY2021 dei City Area Code
CityAreaCode
646
CY2021 dei Local Phone Number
LocalPhoneNumber
432-0610
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2021 dei Entity Shell Company
EntityShellCompany
true
CY2021Q2 dei Entity Public Float
EntityPublicFloat
333200000
CY2021 dei Auditor Name
AuditorName
WithumSmith+Brown, PC
CY2021 dei Auditor Location
AuditorLocation
New York, New York
CY2021 dei Auditor Firm
AuditorFirmId
100
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
479694
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2245798
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
111667
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
275652
CY2021Q4 us-gaap Assets Current
AssetsCurrent
591361
CY2020Q4 us-gaap Assets Current
AssetsCurrent
2521450
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
334441194
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
334321131
CY2021Q4 us-gaap Assets
Assets
335032555
CY2020Q4 us-gaap Assets
Assets
336842581
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3867106
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
208129
CY2021Q4 twnd Accrued Offering Costs
AccruedOfferingCosts
109000
CY2020Q4 twnd Accrued Offering Costs
AccruedOfferingCosts
126000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3976106
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
334129
CY2021Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
13733608
CY2020Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
36975099
CY2021Q4 twnd Deferred Underwriting Fees Noncurrent
DeferredUnderwritingFeesNoncurrent
11697550
CY2020Q4 twnd Deferred Underwriting Fees Noncurrent
DeferredUnderwritingFeesNoncurrent
11697550
CY2021Q4 us-gaap Liabilities
Liabilities
29407264
CY2020Q4 us-gaap Liabilities
Liabilities
49006778
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
334215700
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
334215700
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28591245
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46380733
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-28590409
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-46379897
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
335032555
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
336842581
CY2021 twnd Formation And Operating Costs
FormationAndOperatingCosts
5572066
twnd Formation And Operating Costs
FormationAndOperatingCosts
387335
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-5572066
us-gaap Operating Income Loss
OperatingIncomeLoss
-387355
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
120063
us-gaap Investment Income Interest
InvestmentIncomeInterest
105431
twnd Transaction Costs Associated With Initial Public Offering
TransactionCostsAssociatedWithInitialPublicOffering
715720
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-23241491
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
16902902
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23361554
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17513191
CY2021 us-gaap Net Income Loss
NetIncomeLoss
17789488
us-gaap Net Income Loss
NetIncomeLoss
-17900526
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
0
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2328000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
30832371
us-gaap Net Income Loss
NetIncomeLoss
-17900526
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-46379897
CY2021 us-gaap Net Income Loss
NetIncomeLoss
17789488
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-28590409
CY2021 us-gaap Profit Loss
ProfitLoss
17789488
us-gaap Profit Loss
ProfitLoss
-17900526
CY2021 twnd Changes In Fair Value Adjustment Of Warrants
ChangesInFairValueAdjustmentOfWarrants
-23241491
twnd Changes In Fair Value Adjustment Of Warrants
ChangesInFairValueAdjustmentOfWarrants
16902902
twnd Transaction Costs Associated With Initial Public Offering
TransactionCostsAssociatedWithInitialPublicOffering
715720
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
120063
us-gaap Investment Income Interest
InvestmentIncomeInterest
105431
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-163985
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
275652
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3658977
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
208129
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1749104
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-454858
twnd Cash Invested In Trust Account
CashInvestedInTrustAccount
334215700
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-334215700
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
327531386
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
9700000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
52250
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
17000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
287780
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
336916356
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2245798
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2245798
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
479694
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2245798
twnd Accretion To Class Common Stock Subject To Redemption Value
AccretionToClassCommonStockSubjectToRedemptionValue
30832371
twnd Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
126000
twnd Deferred Offering Costs Paid Through Related Party Debt
DeferredOfferingCostsPaidThroughRelatedPartyDebt
52250
twnd Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
11697550
CY2021 twnd Percentage Of Aggregate Fair Market Value Of Asset
PercentageOfAggregateFairMarketValueOfAsset
0.80
CY2021 twnd Business Acquisition Percentage Of Voting Interests To Be Acquired On Post Transaction Entity Minimum
BusinessAcquisitionPercentageOfVotingInterestsToBeAcquiredOnPostTransactionEntityMinimum
0.50
CY2021 twnd Per Share Value Of Residual Assets Remaining Available For Distribution Which Is Held In Trust Account
PerShareValueOfResidualAssetsRemainingAvailableForDistributionWhichIsHeldInTrustAccount
10.00
CY2021 twnd Minimum Net Tangible Assets Upon Consummation Of Business Combination
MinimumNetTangibleAssetsUponConsummationOfBusinessCombination
5000001
CY2021 twnd Redemption Of Percentage Of Common Stock Included In Units Sold In Offering
RedemptionOfPercentageOfCommonStockIncludedInUnitsSoldInOffering
0.15
CY2021 twnd Interest To Pay Dissolution Expenses
InterestToPayDissolutionExpenses
100000
CY2021Q4 twnd Amount Available In Operating Bank Account
AmountAvailableInOperatingBankAccount
479694
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
479694
CY2021 twnd Working Capital
WorkingCapital
3279558
CY2021Q4 twnd Working Capital Deficit
WorkingCapitalDeficit
3279558
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-style:normal;font-weight:bold;">Use of Estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
334215700
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
12700197
twnd Temporary Equity Issuance Costs
TemporaryEquityIssuanceCosts
18132174
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
30832371
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
334215700
CY2021 twnd Temporary Equity Issuance Costs
TemporaryEquityIssuanceCosts
18132174
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q4 twnd Number Of Shares Issued Per Unit
NumberOfSharesIssuedPerUnit
2
CY2021Q4 twnd Number Of Shares Issued Per Unit
NumberOfSharesIssuedPerUnit
2
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-style:normal;font-weight:bold;">Concentration of Credit Risk</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
CY2021Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2772
CY2021Q4 twnd Deferred Underwriting Commissions
DeferredUnderwritingCommissions
11697550
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
1
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
19569
CY2021Q4 twnd Deferred Tax Assets Startup And Organizational Expenses
DeferredTaxAssetsStartupAndOrganizationalExpenses
1184552
CY2020Q4 twnd Deferred Tax Assets Startup And Organizational Expenses
DeferredTaxAssetsStartupAndOrganizationalExpenses
56428
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1204121
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
59200
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1204121
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
59200
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1144921
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
59200
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1144921
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
59200
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
93186
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
13199
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1144921
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
59200
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.000
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.000
CY2021 twnd Effective Income Tax Rate Reconciliation Change In Deferred Tax Asset Warrant Liability Percent
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetWarrantLiabilityPercent
-0.274
twnd Effective Income Tax Rate Reconciliation Change In Deferred Tax Asset Warrant Liability Percent
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetWarrantLiabilityPercent
-0.198
CY2021 twnd Effective Income Tax Rate Reconciliation Change In Transaction Costs Attributable To Initial Public Offering Percent
EffectiveIncomeTaxRateReconciliationChangeInTransactionCostsAttributableToInitialPublicOfferingPercent
0.000
twnd Effective Income Tax Rate Reconciliation Change In Transaction Costs Attributable To Initial Public Offering Percent
EffectiveIncomeTaxRateReconciliationChangeInTransactionCostsAttributableToInitialPublicOfferingPercent
-0.008
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.064
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.003
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2021Q4 twnd Marketable Securities Held In Trust Account
MarketableSecuritiesHeldInTrustAccount
2040
CY2021Q4 twnd Cash Held In Trust Account
CashHeldInTrustAccount
334439154
CY2020Q4 twnd Marketable Securities Held In Trust Account
MarketableSecuritiesHeldInTrustAccount
1138
CY2020Q4 twnd Cash Held In Trust Account
CashHeldInTrustAccount
334319993
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
13580000
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
3686000
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
9894000
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
9894000

Files In Submission

Name View Source Status
0001104659-22-041015-index-headers.html Edgar Link pending
0001104659-22-041015-index.html Edgar Link pending
0001104659-22-041015.txt Edgar Link pending
0001104659-22-041015-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
twnd-20211231.xsd Edgar Link pending
twnd-20211231x10k.htm Edgar Link pending
twnd-20211231x10k_htm.xml Edgar Link completed
twnd-20211231xex31d1.htm Edgar Link pending
twnd-20211231xex31d2.htm Edgar Link pending
twnd-20211231xex32d1.htm Edgar Link pending
twnd-20211231xex32d2.htm Edgar Link pending
twnd-20211231_cal.xml Edgar Link unprocessable
twnd-20211231_def.xml Edgar Link unprocessable
twnd-20211231_lab.xml Edgar Link unprocessable
twnd-20211231_pre.xml Edgar Link unprocessable